As a member, you’ll gain exclusive access to KSA’s vibrant community with events, socials, and specialized tours. Engage with inspiring DEIB programming, professional meetups, and strategic initiatives, shaping Kendall’s future. Benefit from our advocacy platform and amplify your work through our newsletter and network.

Upcoming Member Events

All Events

News & Updates

Sometimes innovation and group thinking are considered to be opposites. However, when faced with unprecedented circumstances that place potential risks on our ability to innovate, having the opportunity to closely engage with and learn from a shared brain trust, comprised of the most brilliant and creative minds and entrepreneurial spirits, we’re guaranteed to experience better outcomes than if we stick to individual thinking."

Head, Johnson & Johnson Innovation, East North America

Michal Preminger, PhD, MBA

Biotech + Life Sciences

Biogen announced that they are investing $250 million in a 20-year initiative to accelerate action on the greatest challenges of our time: climate change, public health, and equity.

Bayer has entered a collaboration agreement with Recursion Pharmaceuticals to strengthen AI-guided drug discovery and advance new treatments for fibrotic diseases of the lung, kidney, heart, and more.

Alnylam Pharmaceuticals won FDA approval for its third medicine in as many years. The drug, Oxlumo, is approved for a rare disorder called primary hyperoxaluria type 1, which can cause kidney and bladder stones.

Broad Institute launches $300 million initiative to fight diseases with artificial intelligence

About

Kendall Square Association Membership